Ozempic’s Wild “Violence” Side Effect

A healthcare professional preparing a syringe from a vial

Drugs designed to quiet your appetite may also be quieting the leap from ugly impulse to actual violence.

Story Snapshot

Rutgers researchers found Ozempic-style drugs cut the usual link between impulsivity and violent crime by roughly 60 percent among current users.
The effect shows up in a large national sample, not a tiny lab experiment, but it is still only an association.
The same brain circuits that kill food cravings may also blunt the rush that turns anger, booze, and bad judgment into a punch or a gunshot.
The study stops short of calling these drugs “anti-violence pills,” and cautious readers should be glad it does.

A weight loss drug that seems to cool hot tempers

Rutgers researchers looked at a national survey of 7,521 American adults and zoomed in on 821 people who had used a glucagon-like peptide-1 medication such as Ozempic or Wegovy at some point.^[3] They split them into former users and current users. Across the whole sample, people who were more impulsive or drank more were also more likely to report violent behavior or violent crime, echoing decades of criminology work.^[3]

When they compared the two groups, something striking appeared. Among former users, impulsive people who drank more also showed much higher rates of violence. Among current users, the same risk factors still mattered, but the link was far weaker.^[3] The connection between impulsivity and violence was about 62 percent weaker in current users; the alcohol–violence link was about 52 percent weaker, and less consistent but still notable.^[1]

What “weakened link” really means in plain English

The study does not say these drugs turn violent people into angels. It says that among people on these medications, the usual straight line from “I am impulsive” to “I did something violent” bends downward. Think of it as friction in the system. Where a former user might go from insult to fistfight in one step, a current user is more likely to feel the flash of anger but not act on it in the same way.^[3]

That pattern fits how glucagon-like peptide-1 medications act in the brain. These drugs plug into satiety and reward pathways that shape hunger, cravings, and how much pleasure people get from food and other rewards.^[15] Other research has tied these drugs to lower odds of several substance use disorders, with large reductions in diagnoses for alcohol, opioid, nicotine, and cocaine problems among users.^[21] That broader behavioral shift hints at a shared “cooling” of reward-driven impulses, not just slimmer waistlines.

Why the mechanism matters for more than weight

Even with all those caveats, the biological story is not hand-waving. Animal work has shown that stimulating glucagon-like peptide-1 receptors can reduce aggressive behavior in male mice after repeated dosing, likely through brain pathways tied to defense of food and mates.^[19] Human genetic work in that same study did not find a simple “aggression gene” in the glucagon-like peptide-1 receptor, which suggests behavior is shaped more by how the system is activated than by a single switch in our DNA.^[19]

A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect how people act on impulses, though researchers stress thhttps://t.co/K2TJUYBY9e

— Michael W. Deem (@Michael_W_Deem) June 17, 2026

A separate large case-control study found that people exposed to these drugs had sharply lower odds of substance use disorders, including about a 74 percent lower odds of alcohol use disorder and similar drops for opioids, nicotine, and cocaine.^[21] The authors linked this to changes in the reward circuits that drive craving and compulsive seeking of a “high.”^[21] If a drug turns down those circuits, it is reasonable to think it could also soften the rush from rage, alcohol, or thrill-seeking that often sits right before a violent act.

What this means for policy, crime, and personal responsibility

Some headlines leap straight to “Ozempic cuts violent crime.” That jump is not just sloppy; it is dangerous. A free society built on personal responsibility cannot outsource moral behavior to a prescription pad based on one observational survey. The more sober read is this: these medications may make it easier for some high-risk people to pause between impulse and action. That pause is also what good parenting, strong communities, and real faith often try to build.

Future work needs to hit three marks before anyone talks about policy: track people over time to see if starting the drug changes their actual arrest or conviction records; control for mental health, substance use, and background as tightly as possible; and test whether changes in impulsivity and craving really sit in the causal chain.^[3] Until then, the Rutgers study is best seen as an intriguing signal. It does not replace the hard work of building character, but it does show that biology and behavior are not living in separate worlds.